EA
MDCO

Emerald Acquisition’s Medicines Co MDCO Stock Holding History

Emerald Acquisition’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$214K Sell
5,660
-2,014
-26% -$75.9K ﹤0.01% 2669
2016
Q2 		$258K Buy
+7,674
New +$271K ﹤0.01% 2671

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Emerald Acquisition's MDCO Position: Q3 2016 in Review

Emerald Acquisition reduced its Medicines Co (MDCO) stake by 26% in Q3 2016, selling an estimated $75.9K and leaving 5,660 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #2669.

Emerald Acquisition first reported a position in MDCO in Q2 2016 and has held it in 2 quarters since. The position peaked at $258K in Q2 2016. 201 funds tracked by Wall St. Rank hold MDCO as of Q3 2016.

  • Emerald Acquisition held 5,660 shares of Medicines Co worth $214K as of Q3 2016.
  • Emerald Acquisition sold 2,014 Medicines Co shares in Q3 2016, an estimated $75.9K.
  • Medicines Co made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2669 holding.
  • Emerald Acquisition first reported a position in Medicines Co in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Medicines Co position peaked at $258K in Q2 2016.
  • 201 funds tracked by Wall St. Rank held Medicines Co as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.